Atrial Fibrillation clinical trials
- Phase
- Phase 3
- Phase
- Phase 1
- Phase
- Phase 4
Access comprehensive clinical trial information for Atrial Fibrillation through Pure Global AI's free database. This collection includes 1,480 clinical trials across multiple phases including N/A, Phase 4, Phase 3. Currently, 294 trials are actively recruiting participants.
Research for Atrial Fibrillation is being conducted in United States of America, China, South Korea and 7+ other countries. Leading sponsors include Bayer and Boehringer Ingelheim. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,480 clinical trials studying Atrial Fibrillation, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Bayer, Boehringer Ingelheim, Yonsei University, among others.